Filed: 11/14/2023ACC: 0001214659-23-015129
📋 What this filing means
OCTAGON CAPITAL ADVISORS LP filed this quarterly 13F‑HR report disclosing 37 equity positions with a total reported market value of $650.90M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
37
Positions
$650.90M
Total AUM (reported)
59.02M
Total Shares
Allocation by class
COM$493.21M75.8%
SHS$51.01M7.8%
SPONSORED ADS$41.69M6.4%
COM PAR $.01$32.42M5.0%
COM NEW$23.35M3.6%
COM SHS$8.78M1.3%
ADS$453.6K0.1%
Portfolio Concentration
Top 3$257.69M39.6%
4–10$219.82M33.8%
11–25$143.68M22.1%
Rest$29.72M4.6%
Top 3 weight
39.6%
Top 10 weight
73.4%
Voting Authority Distribution
Total shares with voting rights: 59.02M
Sole
Full voting authority
59.02M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole37
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings37
Rows:
APELLIS PHARMACEUTICALS INC
SOLEShares4.21M
TypeSH
Market value$159.96M
24.57%
Sole
4.21M
Shared
0.00
None
0.00
ROIVANT SCIENCES LTD
SOLEShares4.37M
TypeSH
Market value$51.01M
7.84%
Sole
4.37M
Shared
0.00
None
0.00
CYMABAY THERAPEUTICS INC
SOLEShares3.13M
TypeSH
Market value$46.72M
7.18%
Sole
3.13M
Shared
0.00
None
0.00
VERONA PHARMA PLC
SOLEShares2.37M
TypeSH
Market value$38.61M
5.93%
Sole
2.37M
Shared
0.00
None
0.00
IMMUNOVANT INC
SOLEShares1M
TypeSH
Market value$38.39M
5.90%
Sole
1M
Shared
0.00
None
0.00
ARCUS BIOSCIENCES INC
SOLEShares1.97M
TypeSH
Market value$35.33M
5.43%
Sole
1.97M
Shared
0.00
None
0.00
INSMED INC
SOLEShares1.28M
TypeSH
Market value$32.42M
4.98%
Sole
1.28M
Shared
0.00
None
0.00
MIRATI THERAPEUTICS INC
SOLEShares655.05K
TypeSH
Market value$28.53M
4.38%
Sole
655.05K
Shared
0.00
None
0.00
BRIDGEBIO PHARMA INC
SOLEShares971.64K
TypeSH
Market value$25.62M
3.94%
Sole
971.64K
Shared
0.00
None
0.00
CELLDEX THERAPEUTICS INC NEW
SOLEShares759.90K
TypeSH
Market value$20.91M
3.21%
Sole
759.90K
Shared
0.00
None
0.00
89BIO INC
SOLEShares1.22M
TypeSH
Market value$18.82M
2.89%
Sole
1.22M
Shared
0.00
None
0.00
RENEO PHARMACEUTICALS INC
SOLEShares2.28M
TypeSH
Market value$17.36M
2.67%
Sole
2.28M
Shared
0.00
None
0.00
VIRIDIAN THERAPEUTICS INC
SOLEShares1.07M
TypeSH
Market value$16.37M
2.51%
Sole
1.07M
Shared
0.00
None
0.00
AN2 THERAPEUTICS INC
SOLEShares867.58K
TypeSH
Market value$13.95M
2.14%
Sole
867.58K
Shared
0.00
None
0.00
AMYLYX PHARMACEUTICALS INC
SOLEShares695K
TypeSH
Market value$12.73M
1.96%
Sole
695K
Shared
0.00
None
0.00
TAYSHA GENE THERAPIES INC
SOLEShares2.78M
TypeSH
Market value$8.78M
1.35%
Sole
2.78M
Shared
0.00
None
0.00
ALPINE IMMUNE SCIENCES INC
SOLEShares750K
TypeSH
Market value$8.59M
1.32%
Sole
750K
Shared
0.00
None
0.00
GOSSAMER BIO INC
SOLEShares8.19M
TypeSH
Market value$6.82M
1.05%
Sole
8.19M
Shared
0.00
None
0.00
AEROVATE THERAPEUTICS INC
SOLEShares497.37K
TypeSH
Market value$6.75M
1.04%
Sole
497.37K
Shared
0.00
None
0.00
DIANTHUS THERAPEUTICS INC
SOLEShares480K
TypeSH
Market value$6.56M
1.01%
Sole
480K
Shared
0.00
None
0.00
DYNE THERAPEUTICS INC
SOLEShares692.95K
TypeSH
Market value$6.21M
0.95%
Sole
692.95K
Shared
0.00
None
0.00
PMV PHARMACEUTICALS INC
SOLEShares904K
TypeSH
Market value$5.55M
0.85%
Sole
904K
Shared
0.00
None
0.00
INOZYME PHARMA INC
SOLEShares1.30M
TypeSH
Market value$5.46M
0.84%
Sole
1.30M
Shared
0.00
None
0.00
XILIO THERAPEUTICS INC
SOLEShares2.32M
TypeSH
Market value$4.89M
0.75%
Sole
2.32M
Shared
0.00
None
0.00
ANNEXON INC
SOLEShares2.05M
TypeSH
Market value$4.84M
0.74%
Sole
2.05M
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
APELLIS PHARMACEUTICALS INCSOLE | COM | 4.21M | SH | $159.96M 24.57% | 4.21M | 0.00 | 0.00 |
ROIVANT SCIENCES LTDSOLE | SHS | 4.37M | SH | $51.01M 7.84% | 4.37M | 0.00 | 0.00 |
CYMABAY THERAPEUTICS INCSOLE | COM | 3.13M | SH | $46.72M 7.18% | 3.13M | 0.00 | 0.00 |
VERONA PHARMA PLCSOLE | SPONSORED ADS | 2.37M | SH | $38.61M 5.93% | 2.37M | 0.00 | 0.00 |
IMMUNOVANT INCSOLE | COM | 1M | SH | $38.39M 5.90% | 1M | 0.00 | 0.00 |
ARCUS BIOSCIENCES INCSOLE | COM | 1.97M | SH | $35.33M 5.43% | 1.97M | 0.00 | 0.00 |
INSMED INCSOLE | COM PAR $.01 | 1.28M | SH | $32.42M 4.98% | 1.28M | 0.00 | 0.00 |
MIRATI THERAPEUTICS INCSOLE | COM | 655.05K | SH | $28.53M 4.38% | 655.05K | 0.00 | 0.00 |
BRIDGEBIO PHARMA INCSOLE | COM | 971.64K | SH | $25.62M 3.94% | 971.64K | 0.00 | 0.00 |
CELLDEX THERAPEUTICS INC NEWSOLE | COM NEW | 759.90K | SH | $20.91M 3.21% | 759.90K | 0.00 | 0.00 |
89BIO INCSOLE | COM | 1.22M | SH | $18.82M 2.89% | 1.22M | 0.00 | 0.00 |
RENEO PHARMACEUTICALS INCSOLE | COM | 2.28M | SH | $17.36M 2.67% | 2.28M | 0.00 | 0.00 |
VIRIDIAN THERAPEUTICS INCSOLE | COM | 1.07M | SH | $16.37M 2.51% | 1.07M | 0.00 | 0.00 |
AN2 THERAPEUTICS INCSOLE | COM | 867.58K | SH | $13.95M 2.14% | 867.58K | 0.00 | 0.00 |
AMYLYX PHARMACEUTICALS INCSOLE | COM | 695K | SH | $12.73M 1.96% | 695K | 0.00 | 0.00 |
TAYSHA GENE THERAPIES INCSOLE | COM SHS | 2.78M | SH | $8.78M 1.35% | 2.78M | 0.00 | 0.00 |
ALPINE IMMUNE SCIENCES INCSOLE | COM | 750K | SH | $8.59M 1.32% | 750K | 0.00 | 0.00 |
GOSSAMER BIO INCSOLE | COM | 8.19M | SH | $6.82M 1.05% | 8.19M | 0.00 | 0.00 |
AEROVATE THERAPEUTICS INCSOLE | COM | 497.37K | SH | $6.75M 1.04% | 497.37K | 0.00 | 0.00 |
DIANTHUS THERAPEUTICS INCSOLE | COM | 480K | SH | $6.56M 1.01% | 480K | 0.00 | 0.00 |
DYNE THERAPEUTICS INCSOLE | COM | 692.95K | SH | $6.21M 0.95% | 692.95K | 0.00 | 0.00 |
PMV PHARMACEUTICALS INCSOLE | COM | 904K | SH | $5.55M 0.85% | 904K | 0.00 | 0.00 |
INOZYME PHARMA INCSOLE | COM | 1.30M | SH | $5.46M 0.84% | 1.30M | 0.00 | 0.00 |
XILIO THERAPEUTICS INCSOLE | COM | 2.32M | SH | $4.89M 0.75% | 2.32M | 0.00 | 0.00 |
ANNEXON INCSOLE | COM | 2.05M | SH | $4.84M 0.74% | 2.05M | 0.00 | 0.00 |
Page 1 of 2